ConductScience.org, home

Paper26330427

New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.

Lim J and 2 others. Clin Cancer Res, 2015. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype. Papers, record 26330427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26330427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2021-01-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lim JJamie
2Poulin NMNeal M
3Nielsen TOTorsten O

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SarcomaMajor topic
Animals
Epigenesis, Genetic
Genomics
Histone Deacetylase Inhibitors
Humans
Immunotherapy
Molecular Diagnostic Techniques
Precision Medicine

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
41872897Multicenter peritumoral radiomics in oncology: advances, challenges, and future directions.Radiat Oncol2026https://conductscience.org/library/papers/41872897PubMed
41448855Periostin Promotes Sarcoma Growth by Promoting Tumor-Associated Macrophage Migration and Differentiation.Cancer Res Commun2025https://conductscience.org/library/papers/41448855PubMed
39737219Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial.EClinicalMedicine2025https://conductscience.org/library/papers/39737219PubMed
38868205Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines.iScience2024https://conductscience.org/library/papers/38868205PubMed
36438917Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.Int J Med Sci2022https://conductscience.org/library/papers/36438917PubMed
36433954circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment.Nat Commun2022https://conductscience.org/library/papers/36433954PubMed
34925348Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review.Front Immunol2021https://conductscience.org/library/papers/34925348PubMed
34299136Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.Int J Mol Sci2021https://conductscience.org/library/papers/34299136PubMed
34201149Sarcoma Metabolomics: Current Horizons and Future Perspectives.Cells2021https://conductscience.org/library/papers/34201149PubMed
33388091Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes.Hereditas2021https://conductscience.org/library/papers/33388091PubMed
32977646Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients.Cancers (Basel)2020https://conductscience.org/library/papers/32977646PubMed
32503133Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.Cells2020https://conductscience.org/library/papers/32503133PubMed
31988250TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).Mol Cancer Res2020https://conductscience.org/library/papers/31988250PubMed
30545340The changing landscape of phase II/III metastatic sarcoma clinical trials-analysis of ClinicalTrials.gov.BMC Cancer2018https://conductscience.org/library/papers/30545340PubMed
30249211Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.BMC Cancer2018https://conductscience.org/library/papers/30249211PubMed
29490948YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.Cancer Res2018https://conductscience.org/library/papers/29490948PubMed
29351847Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.Mol Cell2018https://conductscience.org/library/papers/29351847PubMed
29308311Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.Oncoimmunology2018https://conductscience.org/library/papers/29308311PubMed
29308306
Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.
Oncoimmunology2018https://conductscience.org/library/papers/29308306PubMed
28656259Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Oncol Rep2017https://conductscience.org/library/papers/28656259PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26330427

GET https://conductscience.org/api/papers/v1/26330427/cited_by?page=2